You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 4, 2026

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
Li-Wen Xia1,2, Meng-Yu Ba1,2, Wei Liu3
1School of Pharmaceutical Science, Zhengzhou University, Zhengzhou, Henan 450001, China.
Proteolysis targeting chimeras (PROTACs) offer a novel therapeutic strategy by degrading target proteins. Triazole-based PROTACs show significant anticancer potential, highlighting their structure-activity relationship for drug development.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: